In the video, Professor Dr. Brenda Penninx highlights a significant increase in the prevalence of anxiety disorders, with a 50% rise over the last decade, affecting about 10% of the population. This trend is observed in both psychiatric epidemiological studies and medical healthcare data, particularly among younger adults and adolescents. Anxiety disorders have a substantial impact on the burden of disease, ranking among the top 10 disorders by WHO, due to their extensive disability effects on work, social, and overall functioning. The early onset of these disorders can lead to a lifelong burden, emphasizing the need for concern and action. 

Professor Dr. Brenda Penninx
Amsterdam UMC, Department of Psychiatry, The Netherlands 

Related content

What Factors Influence the Course and Progression of Anxiety Disorders? play_circle Video play_circle
What Factors Influence the Course and Progression of Anxiety Disorders?

In this video, Professor Dr. Dan Stein highlights the dynamic nature of anxiety disorders, emphasizing the need to re-conceptualize them from a course perspective.

01.10.2025 Anxiety Disorders
What Explains Anxiety’s High Comorbidity? play_circle Video play_circle
What Explains Anxiety’s High Comorbidity?

In this video, Professor Dr. Milan Latas highlights the high prevalence of comorbidity in anxiety disorders, with 50% or more of patients having additional psychiatric conditions

01.10.2025 Anxiety Disorders
How Do Psychotherapeutic and Pharmacological Treatments Complement Each Other in Anxiety Care? play_circle Video play_circle
How Do Psychotherapeutic and Pharmacological Treatments Complement Each Other in Anxiety Care?

In this video, Professor Dr. David Baldwin highlights the dual treatment approaches for anxiety disorders: pharmacological and psychotherapeutic treatments.

01.10.2025 Anxiety Disorders